About Carl Gordon
Carl Gordon is a director and 10% owner at ADARx Pharmaceuticals.
Form D filings also name Carl Gordon as a director at BlossomHill Therapeutics, Avenzo Therapeutics and Garuda Therapeutics.
Carl Gordon reports to the SEC as a director or major shareholder of 29 public companies, including Electra Therapeutics (ETRA), BlossomHill Therapeutics (BLSM) and Scribe Therapeutics (SCTX).
Carl Gordon first appears on SEC filings in 2006.
Experience
This experience comes from SEC filings. The years are when the filings name Carl Gordon in the role, so the role may have started earlier or lasted longer.
EI
SI
Scribe Therapeutics, Inc.
Director
2026 · Public company (SCTX)
CI
Compass Therapeutics, Inc.
Director and 10% owner
2020 – 2026 · Public company (CMPX)
KI
Keros Therapeutics, Inc.
Director
2020 – 2025 · Public company (KROS)
MI
MBX Biosciences, Inc.
Director and 10% owner
2024 – 2025 · Public company (MBX)
LI
Lomond Therapeutics Holdings, Inc.
Director
2024 · Public company
AI
Adicet Bio, Inc.
Director and 10% owner
2020 – 2024 · Public company (ACET)
TI
Terns Pharmaceuticals, Inc.
Director and 10% owner
2021 – 2024 · Public company (TERN)
BI
BiomX Inc.
10% owner
2023 – 2024 · Public company (PHGE)
KI
Kinnate Biopharma Inc.
Director and 10% owner
2020 – 2024 · Public company (KNTE)
TI
Theseus Pharmaceuticals, Inc.
Director and 10% owner
2021 – 2024 · Public company (THRX)
AI
ArriVent BioPharma, Inc.
Director and 10% owner
2024 · Public company (AVBP)
DI
Disc Medicine, Inc.
Director and 10% owner
2021 · Public company (IRON)
OI
Oric Pharmaceuticals, Inc.
Director and 10% owner
2020 – 2021 · Public company (ORIC)
PI
Prevail Therapeutics Inc.
Director and 10% owner
2019 – 2021 · Public company (PRVL)
TI
Turning Point Therapeutics, Inc.
Director
2019 – 2020 · Public company (TPTX)
SI
SpringWorks Therapeutics, Inc.
Director and 10% owner
2019 · Public company (SWTX)
AI
Alector, Inc.
Director and 10% owner
2019 · Public company (ALEC)
AI
ARMO BioSciences, Inc.
Director and 10% owner
2018 · Public company (ARMO)
XI
X4 Pharmaceuticals, Inc
Director and 10% owner
2017 – 2018 · Public company (XFOR)
II
Intellia Therapeutics, Inc.
Director and 10% owner
2016 – 2017 · Public company (NTLA)
CI
Cartesian Therapeutics, Inc.
Director and 10% owner
2016 · Public company (RNAC)
AI
Acceleron Pharma Inc.
Director
2013 · Public company (XLRN)
AP
Amarin Corp. PLC
Director
2010 – 2012 · Public company (AMRN)
CI
Complete Genomics Inc.
Director
2010 – 2012 · Public company (GNOM)
PI
Pacira BioSciences, Inc.
Director
2011 · Public company (PCRX)
BI
Biocryst Pharmaceuticals Inc.
Director
2006 · Public company (BCRX)
Key Colleagues at Startups
The people Carl Gordon works with at each company, as listed on that company's latest Form D.
BlossomHill Therapeutics, Inc. · Form D, Dec 10, 2025
GL
George Lee
Director
YL
Yishan Li
Executive officer and director
SA
Sundeep Agrawal
Director
BC
Bihua Chen
Director
TS
Timothy Stubbs
Director
JC
Jingrong Jean Cui
President and Chief Executive Officer, director
Avenzo Therapeutics, Inc. · Form D, Sep 5, 2025
GN
Garry Nicholson
Director
PM
Patrick Machado
Director
JL
Judith Li
Director
PT
Paolo Tombesi
Executive officer
MH
Mohammad Hirmand
Executive officer
SG
Simeon George
Director
SL
Scott Lipman
Executive officer
AC
Athena Countouriotis
Executive officer and director
BS
Brian Sun
Executive officer
JA
Jakob Dupont, M.D., M.A.
Director
Garuda Therapeutics, Inc. · Form D, Oct 31, 2024
GM
Geoff Meyerson
Director
RK
Raymond Kelleher
Director
EA
Eric Aguiar
Director
SL
Steve Liapis
Director
RS
Rahul Singhvi
Director
DK
David Kirske
Executive officer
AC
Adam Craig
President and CEO, director
ADARx Pharmaceuticals, Inc. · Form D, Aug 10, 2023
RZ
Rui Zhu
Executive officer
SG
Simeon George
Director
JL
Judith Li
Director
Erez Chimovits
Director
SG
Sheila Gujrathi
Director
ZL
Zhen Li
President and Chief Executive Officer, director
YS
Yuan (Eliza) Sun
Director
CY
Chen Yu
Director
RS
Ricky Sun
Director
LK
Lorence Kim
Director